Current Neurovascular Research
Title:Circadian Clock Genes: Targeting Innate Immunity for Antiviral Strategies Against COVID-19
Volume: 17 Issue: 5
Author(s): Kenneth Maiese
Affiliation:
Export Options
About this article
Cite this article as:
Maiese Kenneth , Circadian Clock Genes: Targeting Innate Immunity for Antiviral Strategies Against COVID-19, Current Neurovascular Research 2020; 17 (5) . https://dx.doi.org/10.2174/1567202617666201203110008
DOI https://dx.doi.org/10.2174/1567202617666201203110008 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
22
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Antimicrobial Approaches: Reuse of Old Drugs
Current Drug Targets COVID-19: A Review on Epidemiology, Clinical Features and Possible Potential Drugs Based on Available Case Studies
Coronaviruses A Journey of Coronaviruses from Sporadic Outbreaks to COVID-19 Pandemic
Coronaviruses Misinformation About COVID-19 and Confidential Information Leakage: Impacts on the Psychological Well-being of Indians
Current Psychiatry Research and Reviews COVID-19 and Infectious Disease Speciality - A Necessity of Time in India
Infectious Disorders - Drug Targets New Analogues of Mycophenolic Acid
Mini-Reviews in Medicinal Chemistry Overview of Covid-19 Regarding the Cardiovascular Situation in the Light of Current Reports
Cardiovascular & Hematological Disorders-Drug Targets Challenges of Covid-19 on Adolescent Psychiatric Service Provision in an Independent Inpatient and Outpatient Setting
Adolescent Psychiatry Prognosticating the Spread of Covid-19 Pandemic Based on Optimal Arima Estimators
Endocrine, Metabolic & Immune Disorders - Drug Targets Hydrogen Gas Therapy: From Preclinical Studies to Clinical Trials
Current Pharmaceutical Design <i>In Silico</i> Approach to Predict the SARS-COV2 Derived Candidate MiRNAs as a Potential Antiviral Therapy
Current Drug Therapy Coronavirus (COVID-19) and Employee Health
Coronaviruses A Mechanistic Review on Plant-derived Natural Inhibitors of Human Coronaviruses with Emphasis on SARS-COV-1 and SARS-COV-2
Current Drug Targets Construction, Expression, Purification and Biotin Labeling of a Single Recombinant Multi-Epitope Antigen for Double-Antigen Sandwich ELISA to Detect Hepatitis C Virus Antibody
Protein & Peptide Letters A Flash on Cell Therapy Strategies in Clinical Trials against SARS-CoV-2
Coronaviruses The Acute Phase Protein α1-Acid Glycoprotein: A Model for Altered Glycosylation During Diseases
Current Protein & Peptide Science Withdrawal Notice: The Relationship between Opium Use and Coronavirus Infection: A Brief Research Report from Iran
Coronaviruses Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management
Current Diabetes Reviews Drug Repurposing Approaches: Existing Leads for Novel Threats and Drug Targets
Current Protein & Peptide Science Understanding the Role of Corona Virus based on Current Scientific Evidence - A Review with Emerging Importance in Pandemic
Recent Patents on Anti-Infective Drug Discovery